LOGO.png
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE MINNESOTA VETERINARY MEDICAL ASSOCIATION ANNUAL MEETING IN MINNEAPOLIS, MINNESOTA
January 30, 2023 08:00 ET | PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 30, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
1
PETVIVO HOLDINGS, INC. TO PARTICIPATE IN THE LYTHAM PARTNERS INVESTOR SELECT CONFERENCE
January 26, 2023 08:00 ET | PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
LOGO.png
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 44TH LAKE TAHOE EQUINE CONFERENCE IN INCLINE VILLAGE, NEVADA 
January 23, 2023 10:46 ET | PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 23, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
researchdrivelogo.jpg
Global Companion Animal Arthritis Market Expected to Garner $5,520.5 Million in the 2022-2031 Timeframe, Growing at 7.0% CAGR [250-Pages] | Released by Research Dive
January 23, 2023 09:03 ET | Research Dive
New York, USA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global companion animal arthritis market is predicted to rise at a tremendous CAGR of...
LOGO.png
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 2023 OCALA EQUINE CONFERENCE IN OCALA, FLORIDA
January 17, 2023 08:00 ET | PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 17, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
LOGO.png
PETVIVO HOLDINGS, INC. ANNOUCES PLAN FOR NEW MANUFACTURING FACILITY
January 12, 2023 08:00 ET | PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
LOGO.png
PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA
January 09, 2023 14:03 ET | PetVivo Holdings, Inc.
MINNEAPOLIS, Jan. 09, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
LOGO.png
PetVivo Holdings, Inc. Announces Application for Dual Listing on Upstream
December 28, 2022 08:48 ET | PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Dec. 28, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV, PETVW) (the "Company" or “PetVivo”) an emerging biomedical device company focused on the commercialization of...
petv
New to The Street Resigns PetVivo Holdings, Inc. to New Multi Media TV Broadcasting Deal for 2023
December 19, 2022 09:00 ET | FMW Media Works Corp
NEW YORK, Dec. 19, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street and PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV) announce a new 12-month contract for television airings,...
Graphic 1
Biosplice Announces Interim Data from Phase 3 Long-Term Extension Clinical Trial in Knee Osteoarthritis and the Initiation of a New Phase 3 Trial
December 15, 2022 09:00 ET | Biosplice Therapeutics, Inc.
SAN DIEGO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule...